BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 31521538)

  • 1. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.
    Lerut J; Iesari S; Vandeplas G; Fabbrizio T; Ackenine K; Núñez MEI; Komuta M; Coubeau L; Ciccarelli O; Bonaccorsi-Riani E
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):412-422. PubMed ID: 31521538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult-to-adult living-donor liver transplantation: The experience of the Université catholique de Louvain.
    Iesari S; Inostroza Núñez ME; Rico Juri JM; Ciccarelli O; Bonaccorsi-Riani E; Coubeau L; Laterre PF; Goffette P; De Reyck C; Lengelé B; Gianello P; Lerut J
    Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):132-142. PubMed ID: 30850341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison.
    Wan P; Zhang JJ; Li QG; Xu N; Zhang M; Chen XS; Han LZ; Xia Q
    World J Gastroenterol; 2014 Apr; 20(15):4393-400. PubMed ID: 24764678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation.
    Chok KSH; Chan ACY; Fung JYY; Dai WC; Cheung TT; Lo CM
    Hepatol Int; 2017 Nov; 11(6):517-522. PubMed ID: 28936686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
    Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
    Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM
    Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
    J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
    Reichman TW; Katchman H; Tanaka T; Greig PD; McGilvray ID; Cattral MS; Renner EL; Selzner M; Ghanekar A; Levy G; Grant DR
    Transpl Int; 2013 Aug; 26(8):780-7. PubMed ID: 23746118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
    Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
    World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
    Lei J; Yan L; Wang W
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1340-6. PubMed ID: 23652915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
    Zimmerman MA; Baker T; Goodrich NP; Freise C; Hong JC; Kumer S; Abt P; Cotterell AH; Samstein B; Everhart JE; Merion RM
    Liver Transpl; 2013 Mar; 19(3):259-67. PubMed ID: 23495079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and Safety of Split-Liver Transplantation in a Nascent Framework of Deceased Donation.
    Cherukuru R; Reddy MS; Shanmugam NP; Rajalingam R; Kota V; Gunasekaran V; Narasimhan G; Kaliamoorthy I; Rela M
    Liver Transpl; 2019 Mar; 25(3):450-458. PubMed ID: 30586233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.
    Gan K; Li Z; Bao S; Fang Y; Wang T; Jin L; Ma M; Deng L; Peng Y; Li N; Zeng Z; Huang H
    Transpl Immunol; 2021 Dec; 69():101476. PubMed ID: 34601097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right lobe living donors ages 55 years old and older in liver transplantation.
    Kim SH; Lee EC; Shim JR; Park SJ
    Liver Transpl; 2017 Oct; 23(10):1305-1311. PubMed ID: 28734130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.